1 / 13

Yoongthong W 1 , Kunaratanapruk S 1 , Sumpradit N 1 , Chongtrakul P 2

Assessment of the Selection Process for the 2004 National List for Essential Drugs (NLED) of Thailand . Yoongthong W 1 , Kunaratanapruk S 1 , Sumpradit N 1 , Chongtrakul P 2 1 Thai Food and Drug Administration 2 Chulalongkorn University . Abstract.

oriole
Download Presentation

Yoongthong W 1 , Kunaratanapruk S 1 , Sumpradit N 1 , Chongtrakul P 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Assessment of the Selection Process for the 2004 National List for Essential Drugs (NLED) of Thailand Yoongthong W1, Kunaratanapruk S1, Sumpradit N1, Chongtrakul P2 1 Thai Food and Drug Administration 2 Chulalongkorn University

  2. Abstract Problem Statement: Essential drugs (ED) satisfy the healthcare needs of the majority of the population. They must be effective, safe, and accessible. Careful selection of ED is important because it leads to a higher quality of care, better management of medicines/diseases, and more cost-effective use of health resources; and therefore ultimately improves public health as a whole. To achieve the goal, the ED selection process in Thailand dramatically changed from the use of an implicit system in 1999 (i.e., primarily relying on expert opinions) to an explicit system in 2003 (i.e., evidence-based medicines). In the explicit system, the evidence regarding characteristics of information (I), safety (S), administration restriction (a), frequency of use (f), and efficacy (E) of each medicine is calculated to form an ISafE score. The ISafE score divided by cost per patient per day generates a final score for that medicine. Although a majority of experts in NLED working groups appear to agree on the benefit of the scoring system in ED selection, it is important to evaluate this new method objectively. This study focuses on further understanding the system and how to improve its quality, as well as to promote the system’s sustainability. Objectives: To assess the NLED working groups’ opinions regarding the NLED selection. Specifically, we examine how the working groups think and feel about structure, process, and outcome associated with the establishment of the NLED. Design/Setting/Population: The study is based on a mailed survey with a self-administered questionnaire.Questionnaires were mailed to a total of 270 participants who are physicians and pharmacists officially appointed as experts and secretariats in in the 15 working groups for the NLED selection. Data collection has been conducted during Jan – Feb 2004. Outcome Measures: The questionnaire includes three major domains. The first set of questions relates to the assessment of structure, i.e., informational components and databases used in the NLED selection. The second set of questions involves the evaluation of process, i.e., the transformation of evidence-based drug information into scoring. The third set of questions involves the appraisal of outcomes, i.e., the composition (amounts and items) of the NLED. Responses will be recorded using a five-point scale from 1 (very inappropriate/ dissatisfied) to 5 (very appropriate/satisfied). Personal background will be requested as possible factors affecting opinions. The questionnaire was pre-tested for its validity. Results andConclusions: The preliminary analyses (N = 67) showed that participants thought that publication quality, severity of drug’s risks, efficacy information, and cost is appropriate to use for the NLED selection process (mean scores equal 4.4, 4.2, 4.6, and 4.1, respectively). However, they were not sure about the appropriateness of the use of number of publication/drug’s risks, databases, and scoring transformation (mean scores of 3.7, 3.8, and 3.7, respectively). Overall they were moderately satisfied with the use of scoring system (3.7). Community’s need, NLED philosophy, physician’s experiences, and scoring were major factors that participants mostly used in the NLED selection, whereas influences from drug companies, family/friends, and medical professional association were least likely to be used. Submitted: February 15, 2004 Assessment of 2004 NLED selection-Slide 1- 04.02.04

  3. Introduction • Importance of the National List of Essential Drugs (NLED) • Promote rational use of medicines • The NLED selection is changed. • In 1999, it mostly relied on scoring system that is based on expert opinions. • In 2004, the scoring system was exclusively based on evidence-based materials. However, consensus from the expert panels can modify scoring as appropriate. • NLED Score is a tool to enhance objectivity and systematic approach to the ED selection process. NLED Score = ISafE score / Cost of treatment • ISafE score is derived from an integration of data regarding Information, Safety, administration restriction, frequency of use, and Efficacy Assessment of 2004 NLED selection-Slide 2- 04.02.04

  4. Study framework • Structure–Process–Outcome Model of Quality of Care • Introduced by Avedis Donabedian Assessment of 2004 NLED selection-Slide 3- 04.02.04

  5. Objectives • Goal: • To explore how experts in the NLED working groups think and feel about the 2004 selection process of NLED • Objectives: • Objective # 1: To examine overall opinions about scoring used in the NLED selection • Objective # 2: To explore opinions about approaches and factors used in NLED selection • Objective # 3: To investigate relationships between structure, process, and outcome components of the scoring approach used in the NLED selection Assessment of 2004 NLED selection-Slide 4- 04.02.04

  6. Methods: Classification 15 Working Groups Branch one: NLED Scoring Branch two: Non-NLED scoring • Consists of 4 working groups e.g., • Occupational and Toxicology • Nutrition subgroup • Dentistry • Radiopharmaceuticals • Consists of 11 working groups e.g., • Neurology and Psychiatry • Cardiology • Infectious diseases • Dermatology Questionnaire A Questionnaire B Assessment of 2004 NLED selection-Slide 5- 04.02.04

  7. Methods: Study design Design • Exploratory study based on mailed survey of self-administered questionnaires Data collection procedures • Questionnaires were mailed to all staff members • Follow-up telephone calls were made to non-respondents • Overall response rate was 43% Measures • Structure: Appropriateness of information and databases • Process: Appropriateness of transformation from information to scoring • Outcome: • Satisfaction: Satisfaction with scoring, Satisfaction with the selected items • NLED Quality: Compatibility b/w the selected items with the NLED philosophy, and Amount of the selected items in NLED Assessment of 2004 NLED selection-Slide 6- 04.02.04

  8. Results: Demographics Responses from branch one are displayed for this presentation Assessment of 2004 NLED selection-Slide 7- 04.02.04

  9. Objective # 1: Overall opinions about NLED • Appropriateness/Satisfactory is measured with a 5-point bipolar scale: 5 = very appropriate/satisfied to 1 = very inappropriate/dissatisfied • * Amount of selected items is measured with a 5-point bipolar scale: 5 = too many to 1 = too few. • Compatibility/Understanding is measured a 5-point unipolar scale: 5 = very compatible/well understood to 1 = not at all compatible/understand Assessment of 2004 NLED selection-Slide 8- 04.02.04

  10. Objective # 2: Comparison of approaches and factors used in the NLED selection Approaches used in the NLED selection(1=very inappropriate, 5=very appropriate) Factors used by the panel in NLED selection(1 = never used, 5 = used a lot) Assessment of 2004 NLED selection-Slide 9- 04.02.04

  11. Objective # 3: Structure-Process-Outcome relationship for the scoring approach Information characteristics R2 = 0.08  = 0.78*  = 0.59* Satisfaction with scoring system R2 = 0.32  = 0.15** Process of scoring transformation R2 = 0.25  = 0.56*  = 0.28** Satisfaction with items in NLED R2 = 0.29 Quality of NLED R2 = 0.36 Evidence-based databases  = 0.003 Satisfaction with the use of panel’s judgment in score adjustment  = 0.45* * p < 0.001 ** p < 0.05 Structure Process Intermediate Outcomes Outcome • The panel thought that NLED scoring approach could increase the NLED quality. • Appropriate information increases the appropriateness of the scoring transformation. • When the scoring transformation is appropriate, satisfaction with the scoring system increases. • Satisfaction with scoring system and panel’s judgment in score adjustment leads to the satisfaction with items selected in the NLED • Satisfaction with the items selected into the NLED increases participants’ evaluation of NLED quality. Assessment of 2004 NLED selection-Slide 10- 04.02.04

  12. Discussions • Objective 1: • Participants had favorable opinions about the 2004 NLED scoring approach (i.e., majority of responses had mean scores >= 3.5). This is probably because: • NLED scoring approach may simulate panel’s thinking process of drug evaluation • It is based on well-established clinical evidence, and therefore it is accepted by the panel • The magnitude of favorability may be improved if: • the panels understand NLED scoring approach better (mean score = 3.7) • revisions are made to address the panel’s concerns about NLED scoring approach • Objective 2: NLED Scoring approach with expert opinion is viewed as the most appropriate way. This is probably because: • The combined approach may minimize limitations of each other. • Objective 3: Structure-Process-Outcome relationship • NLED Scoring approach partially addresses participants’ views of the NLED quality • (R2 = 0.36). Assessment of 2004 NLED selection-Slide 11- 04.02.04

  13. Conclusions, Limitations & Recommendations • Conclusions • The 2004 NLED scoring approach is useful for the establishment of the national list of essential medicines. • Limitations • Data collection was conducted during different stages of selection process among working groups • Adoption level of scoring approach is different among working groups • Recommendations • NLED scoring system needs further revisions. • Intensive training for the panel is necessary. Motivation & DTC advertising-Slide 12- 04.01.04 Assessment of 2004 NLED selection-Slide 12- 04.02.04

More Related